In Brief: Fresenius USA
This article was originally published in The Gray Sheet
Executive Summary
Fresenius USA: Dialysis equipment manufacturer plans first quarter 1998 North American roll-out of its On-Line Clearance (OLC) dialysis dose monitor for end stage renal disease patients, the company says. The device, which gained 510(k) clearance in June, can be retrofitted to the Fresenius 2008H dialysis machine and will be included on 70-80% of all new machines sold, the firm says. Unlike competing devices, the OLC immediately provides nephrologists with treatment dose information, Fresenius maintains...